Endralazine
Clinical data | |
---|---|
ATC code | |
Pharmacokinetic data | |
Bioavailability | C14H15N5O |
Identifiers | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Molar mass | 269.3018 |
WikiDoc Resources for Endralazine |
Articles |
---|
Most recent articles on Endralazine Most cited articles on Endralazine |
Media |
Powerpoint slides on Endralazine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Endralazine at Clinical Trials.gov Clinical Trials on Endralazine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Endralazine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Endralazine Discussion groups on Endralazine Patient Handouts on Endralazine Directions to Hospitals Treating Endralazine Risk calculators and risk factors for Endralazine
|
Healthcare Provider Resources |
Causes & Risk Factors for Endralazine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Endralazine is an antihypertensive of the hydrazinophthalazine chemical class.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antihypertensive agents
- Cardiovascular Drugs
- Drug